These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14643959)

  • 1. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
    Roeske JC; Bonta D; Mell LK; Lujan AE; Mundt AJ
    Radiother Oncol; 2003 Nov; 69(2):201-7. PubMed ID: 14643959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
    Mundt AJ; Mell LK; Roeske JC
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1354-60. PubMed ID: 12873680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.
    Mundt AJ; Roeske JC; Lujan AE; Yamada SD; Waggoner SE; Fleming G; Rotmensch J
    Gynecol Oncol; 2001 Sep; 82(3):456-63. PubMed ID: 11520140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.
    Mundt AJ; Lujan AE; Rotmensch J; Waggoner SE; Yamada SD; Fleming G; Roeske JC
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1330-7. PubMed ID: 11955746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
    Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
    Lujan AE; Mundt AJ; Yamada SD; Rotmensch J; Roeske JC
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):516-21. PubMed ID: 12957265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.
    Roeske JC; Lujan A; Rotmensch J; Waggoner SE; Yamada D; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1613-21. PubMed ID: 11121668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy.
    DeFoe SG; Kabolizadeh P; Heron DE; Beriwal S
    Oncology; 2013; 85(1):1-7. PubMed ID: 23736101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
    Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
    Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.
    Simpson DR; Song WY; Moiseenko V; Rose BS; Yashar CM; Mundt AJ; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e81-6. PubMed ID: 22516388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT).
    Yoshimura T; Kinoshita R; Onodera S; Toramatsu C; Suzuki R; Ito YM; Takao S; Matsuura T; Matsuzaki Y; Umegaki K; Shirato H; Shimizu S
    Phys Med; 2016 Sep; 32(9):1095-102. PubMed ID: 27567089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    Cella L; D'Avino V; Liuzzi R; Conson M; Doria F; Faiella A; Loffredo F; Salvatore M; Pacelli R
    Radiat Oncol; 2013 Sep; 8():221. PubMed ID: 24053357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?
    Adli M; Mayr NA; Kaiser HS; Skwarchuk MW; Meeks SL; Mardirossian G; Paulino AC; Montebello JF; Gaston RC; Sorosky JI; Buatti JM
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):230-8. PubMed ID: 12909238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity.
    Jani AB; Su A; Milano MT
    Urology; 2006 Jan; 67(1):147-51. PubMed ID: 16413351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
    Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adipose ratio as a novel predictor for acute bowel toxicity in patients receiving pelvic radiation: Preliminary dosimetric analysis and clinical validation.
    Hoover A; Gunan Ganju R; TenNapel M; Chen A
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):408-414. PubMed ID: 30829461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy.
    Isohashi F; Mabuchi S; Akino Y; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yoshino K; Sawada K; Ueda Y; Kobayashi E; Sumida I; Mizuno H; Okubo H; Kimura T; Ogawa K
    J Radiat Res; 2016 Nov; 57(6):668-676. PubMed ID: 27342839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.